WCN23-0681 Efficacy and safety of sucroferric oxyhydroxide vs sevelamer carbonate in Chinese dialysis patients with hyperphosphataemia

Sucroferric oxyhydroxide (SFOH) is a non-calcium-based, oral iron-containing phosphate binder that has been demonstrated to be efficacious and generally well tolerated for the control of serum phosphorus (sP) in patients with chronic kidney disease undergoing dialysis. This study aimed to investigate the efficacy and safety of SFOH vs sevelamer carbonate in controlling sP in adult Chinese dialysis patients with hyperphosphataemia.